AS1810722 is an orally effective STAT6 inhibitor with an IC50 of 1.9 nM. AS1810722 shows good CYP3A4 inhibition and is a thickened bicyclic pyrimidine derivative with potential for use in allergic disease studies, such as asthma and atopic diseases.
Molecular Weight:
477.51
Purity:
>98.0%
CAS Number:
[909561-15-5]
Formula:
C25H25F2N7O
Target:
STAT
* VAT and and shipping costs not included. Errors and price changes excepted